Stay updated on TAK-659 in AML Clinical Trial

Sign up to get notified when there's something new on the TAK-659 in AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the TAK-659 in AML Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.4%
    Check dated 2025-05-01T05:39:43.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Difference
    0.4%
    Check dated 2025-04-23T22:17:37.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    The page has removed detailed descriptions of a clinical study for TAK-659, including its phases, participant criteria, and treatment protocols for acute myelogenous leukemia (AML). Additionally, it has added references to the condition and registry identifiers.
    Difference
    32%
    Check dated 2025-04-16T14:45:06.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.2%
    Check dated 2025-04-09T10:00:55.000Z thumbnail image
  7. Check
    46 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.2 to version 2.14.3.
    Difference
    0.0%
    Check dated 2025-04-01T23:37:02.000Z thumbnail image
  8. Check
    53 days ago
    Change Detected
    Difference
    0.2%
    Check dated 2025-03-25T14:12:49.000Z thumbnail image

Stay in the know with updates to TAK-659 in AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the TAK-659 in AML Clinical Trial page.